← All trials
NCT06411028
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2025
- Primary completion
- May 30, 2027
- Completion date
- May 30, 2027
- First posted
- May 13, 2024
- Last posted
- Mar 24, 2025
- Enrollment
- 60
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Radboud UniversityLead sponsor
- Canisius-Wilhelmina HospitalCollaborator
- Donders Centre for Cognitive NeuroimagingCollaborator
- Radboud UniversityOfficial
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.